These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16245280)

  • 1. Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer.
    Ozerdem U
    Prostate; 2006 Feb; 66(3):294-304. PubMed ID: 16245280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan.
    Ozerdem U; Stallcup WB
    Angiogenesis; 2004; 7(3):269-76. PubMed ID: 15609081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting pericytes diminishes neovascularization in orthotopic uveal melanoma in nerve/glial antigen 2 proteoglycan knockout mouse.
    Ozerdem U
    Ophthalmic Res; 2006; 38(5):251-4. PubMed ID: 16888406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts.
    Welén K; Jennbacken K; Tesan T; Damber JE
    Prostate Cancer Prostatic Dis; 2009; 12(1):41-6. PubMed ID: 18521102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.
    Bagley RG; Honma N; Weber W; Boutin P; Rouleau C; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA
    Microvasc Res; 2008 Nov; 76(3):180-8. PubMed ID: 18761022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical and opposing roles of the chemokine receptors CXCR2 and CXCR3 in prostate tumor growth.
    Shen H; Schuster R; Lu B; Waltz SE; Lentsch AB
    Prostate; 2006 Dec; 66(16):1721-8. PubMed ID: 16941672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer.
    Bertilaccio MT; Grioni M; Sutherland BW; Degl'Innocenti E; Freschi M; Jachetti E; Greenberg NM; Corti A; Bellone M
    Prostate; 2008 Jul; 68(10):1105-15. PubMed ID: 18437689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting neovascular pericytes in neurofibromatosis type 1.
    Ozerdem U
    Angiogenesis; 2004; 7(4):307-11. PubMed ID: 15886874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis.
    Ozerdem U; Grako KA; Dahlin-Huppe K; Monosov E; Stallcup WB
    Dev Dyn; 2001 Oct; 222(2):218-27. PubMed ID: 11668599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and morphological effects of NG2 proteoglycan deletion on hippocampal neurogenesis.
    Thallmair M; Ray J; Stallcup WB; Gage FH
    Exp Neurol; 2006 Nov; 202(1):167-78. PubMed ID: 16814771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NG2 expression regulates vascular morphology and function in human brain tumours.
    Brekke C; Lundervold A; Enger PØ; Brekken C; Stålsett E; Pedersen TB; Haraldseth O; Krüger PG; Bjerkvig R; Chekenya M
    Neuroimage; 2006 Feb; 29(3):965-76. PubMed ID: 16253523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential responses of spinal axons to transection: influence of the NG2 proteoglycan.
    de Castro R; Tajrishi R; Claros J; Stallcup WB
    Exp Neurol; 2005 Apr; 192(2):299-309. PubMed ID: 15755547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
    Miyahara M; Tanuma J; Sugihara K; Semba I
    Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of angiopoietin-2 and vascular endothelial growth factor in androgen-independent prostate cancer models.
    Tesan T; Gustavsson H; Welén K; Damber JE
    BJU Int; 2008 Sep; 102(8):1034-9. PubMed ID: 18489523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
    Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic utility of quantitative image analysis of microvascular density in prostate cancer.
    Ozerdem U; Wojcik EM; Duan X; Erşahin Ç; Barkan GA
    Pathol Int; 2013 May; 63(5):277-82. PubMed ID: 23714256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of arginase II alters prostate tumor formation in TRAMP mice.
    Mumenthaler SM; Rozengurt N; Livesay JC; Sabaghian A; Cederbaum SD; Grody WW
    Prostate; 2008 Oct; 68(14):1561-9. PubMed ID: 18663728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients.
    Kadota K; Huang CL; Liu D; Ueno M; Kushida Y; Haba R; Yokomise H
    Eur J Cancer; 2008 May; 44(7):1057-67. PubMed ID: 18396396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development.
    Young N; Hahn CN; Poh A; Dong C; Wilhelm D; Olsson J; Muscat GE; Parsons P; Gamble JR; Koopman P
    J Natl Cancer Inst; 2006 Aug; 98(15):1060-7. PubMed ID: 16882943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of VEGF-A/VEGF-C antisense oligodeoxynucleotide on angiogenesis, lymphangiogenesis, and tumor growth of breast cancer].
    Chen JS; Zhang YJ; Hu SE; Zhang HQ
    Ai Zheng; 2007 Sep; 26(9):972-6. PubMed ID: 17927855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.